Soft steroids: a new approach to the treatment of inflammatory airways diseases
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 16 (6) , 321-325
- https://doi.org/10.1016/s1094-5539(03)00105-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseasesLife Sciences, 2003
- Mechanisms involved in the side effects of glucocorticoidsPharmacology & Therapeutics, 2002
- Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation ActivityThe Journal of Immunology, 2001
- Soft drug design: General principles and recent applicationsMedicinal Research Reviews, 2000
- A Dose-dependent Effect of the Novel Inhaled Corticosteroid Ciclesonide on Airway Responsiveness to Adenosine-5 ′ -Monophosphate in Asthmatic PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Anti-inflammatory Actions of Glucocorticoids: Molecular MechanismsClinical Science, 1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Synthetic Glucocorticoids That Dissociate Transactivation and AP-1 Transrepression Exhibit Antiinflammatory Activity in VivoMolecular Endocrinology, 1997
- Rapid metabolic inactivation of tipredane, a structurally novel topical steroidThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- New biologically active pregnan-21-oic acid estersJournal of Steroid Biochemistry, 1975